CASE STUDY: METHODOLOGY IN BUILDING INFORMATION AND EDUCATION RESOURCES FOR A NATIONAL SCREENING PROGRAM Supporting participation paramount in the upcoming National Lung Cancer Screening Program
With
Dr Rachael Dodd
Senior Research Fellow,
The Daffodil Centre, a Cancer Council NSW & The University of Sydney Joint Venture
AUSTRALIAN HEALTH JOURNAL CASE STUDY
Filmed in Sydney | April 2025
At the recent Screening Conference 2025 in Sydney, hosted by Public Health Association, Dr Rachael Dodd, Senior Research Fellow at The Daffodil Centre, spoke about the information and educational resources created to increase awareness in the healthcare workforce and community on the upcoming Australia’s National Lung Cancer Screening Program commencing in July 2025.
A consortium including The Daffodil Centre, Lung Foundation Australia, Cancer Council Victoria and University of Melbourne were engaged by the Australian Government, through Cancer Australia to deliver a suite of information materials, workforce education resources, and a dissemination strategy for the Program, seen as paramount to support participation.
Dr Dodd talked to Australian Health Journal about the qualitative research process over the past 6 years, from a scoping review of existing lung cancer screening (LCS) information materials and messaging and an environmental scan of existing cancer screening program resources to inform initial development of the key messages, proposed information resources and the dissemination strategy. These were further developed through individual interviews and co-design workshops with the healthcare workforce and community members.
The scoping review identified 34 articles reporting strategies to increase awareness and knowledge of LCS. The environmental scan found 13 provider-focused resources and 18 consumer-focused resources across Australian screening programs. Most LCS-specific resources (18 sets) were from the United States, United Kingdom, Canada and Singapore.
Key ideas arising from the consultations (28 community; 35 health workforce) and co-design workshops (2 health workforce (n=41), 1 community (n=18)) were the need for: clear information about eligibility criteria, a pack-year smoking calculator, easy-to-read detail about the National Cancer Screening Register, examples of symptoms of lung cancer, clarity on referral pathways, a centralised website to host resources, videos of the screening process, guidance for ineligible participants, and managing conversations including smoking behaviours, and lung cancer stigma. Digital resources were generally preferred to paper resources.
Source: Adapted from Screening Conference 2025 Abstract Book
-
Evolution of the pharmacy tribe
The past 18 months has shown the strength of Australian pharmacies in ensuring accessibility, credibility and maintaining rapport with the community to administer COVID-19 vaccinations, handle electronic prescriptions and looking to play an integrated role in aged care.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
